The GLOW Blend combines GHK-Cu, TB-500, and BPC-157 — three peptides individually studied in skin, tissue-repair, and regenerative research — into a single research formulation aimed at dermal and connective-tissue…
🔬 Studied for: Skin-Focused Research
💊 Also studied for: Tissue-Remodeling Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
The GLOW Blend combines GHK-Cu, TB-500, and BPC-157 — three peptides individually studied in skin, tissue-repair, and regenerative research — into a single research formulation aimed at dermal and connective-tissue research applications.
The blend pairs GHK-Cu's studied role in collagen synthesis and antioxidant signaling with TB-500 and BPC-157's studied roles in angiogenesis and cell migration, reflecting a research interest in combined pathways relevant to skin and tissue remodeling.
These are effects GLOW Blend (Cu+TB+BPC) has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
GHK-Cu's presence in the blend reflects the substantial dermal-research literature on copper peptides and collagen turnover, extended here alongside peptides studied for broader tissue repair.
TB-500 and BPC-157 contribute mechanisms studied for angiogenesis and connective-tissue repair, an area of overlapping research interest with GHK-Cu's effects on the extracellular matrix.
No clinical or FDA-established human dosage exists for this combination product; any research use should reference the individual peptide literature and appropriate laboratory protocols.
Compound X does not provide dosing recommendations. GLOW Blend (Cu+TB+BPC) is sold for laboratory research use only and is not intended for human consumption.
This combination has not been evaluated as a formulation in controlled human trials. Safety considerations from each individual component (see GHK-Cu, TB-500 and BPC-157 listings) apply, and combination-specific interaction data does not exist.
No. GLOW Blend (Cu+TB+BPC) is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Skin-Focused Research — GHK-Cu's presence in the blend reflects the substantial dermal-research literature on copper peptides and collagen turnover, extended here alongside peptides studied for broader tissue repair.
In the US, UK, Canada and Australia, GLOW Blend (Cu+TB+BPC) is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
See the individual GHK-Cu, TB-500, and BPC-157 research listings for compound-specific peer-reviewed literature.
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.